UroGen Pharma Ltd. (NASDAQ:URGN) Q1 2024 Earnings Call Transcript May 13, 2024
Operator: Good morning ladies and gentlemen. Thank you for standing by. Welcome to the UroGen Pharma First Quarter 2024 Earnings Call. Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your first speaker today, Vincent Perrone, Head of Investor Relations. You may begin.
Vincent Perrone: Thank you, operator. Good morning, everyone, and welcome to UroGen...
